While T cell therapies offer groundbreaking treatment options, they also face several challenges. One major issue is the high cost of treatment, often exceeding hundreds of thousands of dollars. Additionally, the manufacturing process is complex and time-consuming. There is also the risk of relapse, where the cancer returns after initially responding to therapy.
